In pediatric oncology, TKIs are primarily used to treat specific types of cancers, such as chronic myeloid leukemia (CML) and certain types of acute lymphoblastic leukemia (ALL). These drugs have revolutionized the treatment of CML, significantly improving survival rates and quality of life. Some commonly used TKIs in pediatrics include imatinib, dasatinib, and nilotinib.
